{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:26:41Z","timestamp":1787905601294,"version":"build-2784847793"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01558-1","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T08:29:53Z","timestamp":1739608193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review"],"prefix":"10.1007","volume":"40","author":[{"given":"Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5900-0337","authenticated-orcid":false,"given":"Weimin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"1558_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/schbul\/sbaa136","volume":"47","author":"AH Al-Dujaili","year":"2021","unstructured":"Al-Dujaili AH, Mousa RF, Al-Hakeim HK, Maes M (2021) High mobility group protein 1 and dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: associations with interleukin-6, symptom domains, and neurocognitive impairments. Schizophr Bull 47:530\u2013541","journal-title":"Schizophr Bull"},{"key":"1558_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10787-022-01097-6","volume":"31","author":"S Assadiasl","year":"2023","unstructured":"Assadiasl S, Rajabinejad M, Soleimanifar N, Makiyan F, Azizi E, Rezaiemanesh A, Nicknam MH (2023) MicroRNAs-mediated regulation pathways in rheumatic diseases. Inflammopharmacology 31:129\u2013144","journal-title":"Inflammopharmacology"},{"key":"1558_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ajmg.b.30770","volume":"150B","author":"IO Barlas","year":"2009","unstructured":"Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O (2009) Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet Part B: Neuropsychiatric Genet 150B:56\u201360","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"key":"1558_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/schbul\/sbab103","volume":"48","author":"G Blackman","year":"2021","unstructured":"Blackman G, Oloyede E, Horowitz M, Harland R, Taylor D, MacCabe J, McGuire P (2021) Reducing the risk of withdrawal symptoms and relapse following Clozapine Discontinuation\u2014Is it feasible to develop evidence-based guidelines? Schizophr Bull 48:176\u2013189","journal-title":"Schizophr Bull"},{"key":"1558_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12974-017-0962-y","volume":"14","author":"D Boerrigter","year":"2017","unstructured":"Boerrigter D, Weickert TW, Lenroot R, O\u2019Donnell M, Galletly C, Liu D, Burgess M, Cadiz R, Jacomb I, Catts VS, Fillman SG, Weickert CS (2017) Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. J Neuroinflammation 14:188","journal-title":"J Neuroinflammation"},{"key":"1558_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012236.pub2","volume-title":"Interventions for prodromal stage of psychosis","author":"D Bosnjak Kuharic","year":"2019","unstructured":"Bosnjak Kuharic D, Kekin I, Hew J, Rojnic Kuzman M, Puljak L (2019) Interventions for prodromal stage of psychosis. Cochrane Database of Systematic Reviews"},{"key":"1558_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1176\/ajp.155.6.751","volume":"155","author":"RW Buchanan","year":"1998","unstructured":"Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr (1998) Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 155:751\u2013760","journal-title":"Am J Psychiatry"},{"key":"1558_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","volume":"158","author":"M Chakos","year":"2001","unstructured":"Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B (2001) Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 158:518\u2013526","journal-title":"Am J Psychiatry"},{"key":"1558_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.imlet.2011.06.011","volume":"140","author":"ML Chen","year":"2011","unstructured":"Chen ML, Tsai TC, Lin YY, Tsai YM, Wang LK, Lee MC, Tsai FM (2011) Antipsychotic drugs suppress the AKT\/NF-\u03baB pathway and regulate the differentiation of T-cell subsets. Immunol Lett 140:81\u201391","journal-title":"Immunol Lett"},{"key":"1558_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/08923973.2011.651535","volume":"34","author":"ML Chen","year":"2012","unstructured":"Chen ML, Tsai TC, Wang LK, Lin YY, Tsai YM, Lee MC, Tsai FM (2012) Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-\u03b3 production in peripheral blood mononuclear cells. Immunopharmacol Immunotoxicol 34:686\u2013694","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1558_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3109\/08923973.2013.828744","volume":"35","author":"ML Chen","year":"2013","unstructured":"Chen ML, Wu S, Tsai TC, Wang LK, Tsai FM (2013) Regulation of macrophage immune responses by antipsychotic drugs. Immunopharmacol Immunotoxicol 35:573\u2013580","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1558_CR12","volume-title":"Neuroleptic-induced supersensitivity psychosis","author":"G Chouinard","year":"1978","unstructured":"Chouinard G, Jones BD, Annable L (1978) Neuroleptic-induced supersensitivity psychosis. The American journal of psychiatry"},{"key":"1558_CR13","doi-asserted-by":"crossref","unstructured":"Correll CU, Howes OD (2021) Treatment-resistant Schizophrenia: definition, predictors, and Therapy options. J Clin Psychiatry 82:MY20096AH1C","DOI":"10.4088\/JCP.MY20096AH1C"},{"key":"1558_CR14","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.euroneuro.2015.08.004","volume":"25","author":"MC Cotel","year":"2015","unstructured":"Cotel MC, Lenartowicz EM, Natesan S, Modo MM, Cooper JD, Williams SC, Kapur S, Vernon AC (2015) Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. Eur Neuropsychopharmacol 25:2098\u20132107","journal-title":"Eur Neuropsychopharmacol"},{"key":"1558_CR15","first-page":"34","volume":"14","author":"C Dada","year":"2020","unstructured":"Dada C (2020) How clozapine patients can be monitored safely and effectively. Evaluation 14:34","journal-title":"Evaluation"},{"key":"1558_CR16","first-page":"855","volume":"24","author":"W Dameshek","year":"1930","unstructured":"Dameshek W (1930) White blood cells in dementia praecox and dementia paralytica. Arch Neurol Psychiatry 24:855","journal-title":"Arch Neurol Psychiatry"},{"key":"1558_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","volume":"154","author":"L de Witte","year":"2014","unstructured":"de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S (2014) Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res 154:23\u201329","journal-title":"Schizophr Res"},{"key":"1558_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/brainsci14010103","volume":"14","author":"L Dell\u2019Osso","year":"2024","unstructured":"Dell\u2019Osso L, Bonelli C, Nardi B, Giovannoni F, Pronest\u00ec C, Cremone IM, Amatori G, Pini S, Carpita B (2024) Rethinking clozapine: lights and shadows of a Revolutionary Drug. Brain Sci 14:103","journal-title":"Brain Sci"},{"key":"1558_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pnpbp.2012.11.007","volume":"42","author":"S Dodd","year":"2013","unstructured":"Dodd S, Maes M, Anderson G, Dean OM, Moylan S, Berk M (2013) Putative neuroprotective agents in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 42:135\u2013145","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1558_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41537-024-00469-x","volume":"10","author":"Y Dong","year":"2024","unstructured":"Dong Y, Zhu M, Li Y, Liu N, Wang X, Yang B, Li S, Li Z (2024) Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome. Schizophrenia (Heidelb) 10:47","journal-title":"Schizophrenia (Heidelb)"},{"key":"1558_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/ern.09.144","volume":"10","author":"RC Drexhage","year":"2010","unstructured":"Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen Lvd, Beumer W, Versnel MA, Drexhage HA (2010) The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 10:59\u201376","journal-title":"Expert Rev Neurother"},{"key":"1558_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/HAB-180344","volume":"27","author":"MM Eftekharian","year":"2019","unstructured":"Eftekharian MM, Omrani MD, Arsang-Jang S, Taheri M, Ghafouri-Fard S (2019) Serum cytokine profile in schizophrenic patients. Hum Antib 27:23\u201329","journal-title":"Hum Antib"},{"key":"1558_CR23","doi-asserted-by":"crossref","unstructured":"Essali A, Al-Haj Haasan N, Li C, Rathbone J (2009) Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database Syst Rev 2009: Cd000059","DOI":"10.1002\/14651858.CD000059.pub2"},{"key":"1558_CR24","doi-asserted-by":"publisher","first-page":"602121","DOI":"10.3389\/fpsyt.2020.602121","volume":"11","author":"X Fang","year":"2020","unstructured":"Fang X, Yu L, Wang D, Chen Y, Wang Y, Wu Z, Liu R, Ren J, Tang W, Zhang C (2020) Association between SIRT1, Cytokines, and metabolic syndrome in Schizophrenia patients with olanzapine or Clozapine Monotherapy. Front Psychiatry 11:602121","journal-title":"Front Psychiatry"},{"key":"1558_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neubiorev.2013.11.006","volume":"38","author":"KA Feigenson","year":"2014","unstructured":"Feigenson KA, Kusnecov AW, Silverstein SM (2014) Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehavioral Reviews 38:72\u201393","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"1558_CR26","doi-asserted-by":"publisher","first-page":"116823","DOI":"10.1016\/j.jep.2023.116823","volume":"317","author":"D Feng","year":"2023","unstructured":"Feng D, Li P, Xiao W, Pei Z, Chen P, Hu M, Yang Z, Li T, Xia Z, Cui H (2023) N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury. J Ethnopharmacol 317:116823","journal-title":"J Ethnopharmacol"},{"key":"1558_CR27","doi-asserted-by":"publisher","first-page":"e0155631","DOI":"10.1371\/journal.pone.0155631","volume":"11","author":"E Fernandez-Egea","year":"2016","unstructured":"Fernandez-Egea E, Vertes PE, Flint SM, Turner L, Mustafa S, Hatton A, Smith KG, Lyons PA, Bullmore ET (2016) Peripheral immune cell populations associated with cognitive deficits and negative symptoms of treatment-resistant schizophrenia. PLoS ONE 11:e0155631","journal-title":"PLoS ONE"},{"key":"1558_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/mp.2015.90","volume":"21","author":"SG Fillman","year":"2016","unstructured":"Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, Weickert CS (2016) Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca\u2019s area volume. Mol Psychiatry 21:1090\u20131098","journal-title":"Mol Psychiatry"},{"key":"1558_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00406-018-0908-0","volume":"269","author":"G Fond","year":"2019","unstructured":"Fond G, Godin O, Boyer L, Berna F, Andrianarisoa M, Coulon N, Brunel L, Bulzacka E, Aouizerate B, Capdevielle D, Chereau I, D\u2019Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lan\u00e7on C, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Sch\u00fcrhoff F, Leboyer M, Andrianarisoa M, Aouizerate B, Bazin N, Berna F, Blanc O, Brunel L, Bulzacka E, Capdevielle D, Chereau-Boudet I, Chesnoy-Servanin G, Danion JM, D\u2019Amato T, Deloge A, Delorme C, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Fluttaz C, Fond G, Fonteneau S, Gabayet F, Giraud-Baro E, Hardy-Bayle MC, Lacelle D, Lan\u00e7on C, Laouamri H, Leboyer M, Le Gloahec T, Le Strat Y, Llorca PM, Mallet J, Metairie E, Misdrahi D, Offerlin-Meyer I, Passerieux C, Peri P, Pires S, Portalier C, Ramet L, Rey R, Roman C, Sebilleau M, Schandrin A, Sch\u00fcrhoff F, Tessier A, Tronche AM, Urbach M, Vaillant F, Vehier A, Vidailhet P, Vil\u00e0 E, Yazbek H, Zinetti-Bertschy A, the F-SZG (2019) Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci 269:985\u2013992","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1558_CR30","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I (2021) The blood\u2013brain barrier in systemic infection and inflammation. Cell Mol Immunol 18:2489\u20132501","journal-title":"Cell Mol Immunol"},{"key":"1558_CR31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/0269881118760666","volume":"32","author":"SH Gee","year":"2018","unstructured":"Gee SH, Shergill SS, Taylor DM (2018) Long-term follow-up of clozapine prescribing. J Psychopharmacol 32:552\u2013558","journal-title":"J Psychopharmacol"},{"key":"1558_CR32","first-page":"505","volume":"59","author":"M George","year":"2017","unstructured":"George M, Maheshwari S, Chandran S, Manohar JS, Sathyanarayana Rao TS (2017) Understanding the schizophrenia prodrome. Indian J Psychiatry 59:505\u2013509","journal-title":"Indian J Psychiatry"},{"key":"1558_CR33","doi-asserted-by":"crossref","unstructured":"Gillespie AL, Samanaite R, Mill J, Egerton A, MacCabe JH (2017) Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic","DOI":"10.1186\/s12888-016-1177-y"},{"key":"1558_CR34","doi-asserted-by":"crossref","unstructured":"Giridharan VV, Scaini G, Colpo GD, Doifode T, Pinjari OF, Teixeira AL, Petronilho F, Mac\u00eado D, Quevedo J, Barichello T (2020) Clozapine prevents poly (I:C) Induced inflammation by modulating NLRP3 pathway in Microglial cells. Cells 9:577","DOI":"10.3390\/cells9030577"},{"key":"1558_CR35","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696\u20131709","journal-title":"Mol Psychiatry"},{"key":"1558_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbi.2023.10.001","volume":"115","author":"K Griffiths","year":"2024","unstructured":"Griffiths K, Mellado MR, Chung R, Lally J, McQueen G, Sendt KV, Gillespie A, Ibrahim M, Richter A, Shields A, Ponsford M, Jolles S, Hodsoll J, Pollak TA, Upthegrove R, Egerton A, MacCabe JH (2024) Changes in immunoglobulin levels during clozapine treatment in schizophrenia. Brain Behav Immun 115:223\u2013228","journal-title":"Brain Behav Immun"},{"key":"1558_CR37","doi-asserted-by":"publisher","first-page":"1184601","DOI":"10.3389\/fnins.2023.1184601","volume":"17","author":"S Hao","year":"2023","unstructured":"Hao S, Jiali P, Xiaomin Z, Xiaoqin W, Lina L, Xin Q, Qin L (2023) Group identity modulates bidding behavior in repeated lottery contest: neural signatures from event-related potentials and electroencephalography oscillations. Front NeuroSci 17:1184601","journal-title":"Front NeuroSci"},{"key":"1558_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0893-133X(98)00006-2","volume":"19","author":"D Hinze-Selch","year":"1998","unstructured":"Hinze-Selch D, Becker EW, Stein GM, Berg PA, Mullington J, Holsboer F, Pollm\u00e4cher T (1998) Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology 19:114\u2013122","journal-title":"Neuropsychopharmacology"},{"key":"1558_CR39","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1038\/tp.2016.278","volume":"7","author":"O Howes","year":"2017","unstructured":"Howes O, McCutcheon R (2017) Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Translational Psychiatry 7:e1024\u2013e1024","journal-title":"Translational Psychiatry"},{"key":"1558_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13020-023-00745-5","volume":"18","author":"E Hu","year":"2023","unstructured":"Hu E, Li Z, Li T, Yang X, Ding R, Jiang H, Su H, Cheng M, Yu Z, Li H (2023) A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of astragaloside IV on intracerebral hemorrhage as an example. Chin Med 18:40","journal-title":"Chin Med"},{"key":"1558_CR41","first-page":"395","volume":"71","author":"Y-P Hung","year":"2017","unstructured":"Hung Y-P, Wang CS-M, Yen C-N, Chang H-C, Chen PS, Lee IH, Chen KC, Yang YK, Lu R-B, Wang T-Y (2017) Role of cytokine changes in clozapine-induced fever: a cohort prospective study. J Neuropsychiatry Clin Neurosci 71:395\u2013402","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1558_CR42","first-page":"905","volume":"35","author":"G Jin","year":"2019","unstructured":"Jin G, Xu Y, Song Q, Xu W (2019) PANSS, mental condition and inflammatory state of risperidone on schizophrenia. ACTA Med MEDITERRANEA 35:905\u2013908","journal-title":"ACTA Med MEDITERRANEA"},{"key":"1558_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789\u2013796","journal-title":"Arch Gen Psychiatry"},{"key":"1558_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2024.01.035","volume":"268","author":"JM Kane","year":"2024","unstructured":"Kane JM, Schoretsanitis G, Rubio JM, Correll CU (2024) Clozapine in treatment-resistant schizophrenia: reflections from the Hallmark US clinical trial and beyond. Schizophr Res 268:9\u201313","journal-title":"Schizophr Res"},{"key":"1558_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1471-4159.2008.05435.x","volume":"106","author":"T Kato","year":"2008","unstructured":"Kato T, Mizoguchi Y, Monji A, Horikawa H, Suzuki SO, Seki Y, Iwaki T, Hashioka S, Kanba S (2008) Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2\u2009+\u2009regulation in vitro. J Neurochem 106:815\u2013825","journal-title":"J Neurochem"},{"key":"1558_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbi.2016.12.011","volume":"62","author":"S K\u00e9ri","year":"2017","unstructured":"K\u00e9ri S, Szab\u00f3 C, Kelemen O (2017) Antipsychotics influence toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia. Brain Behav Immun 62:256\u2013264","journal-title":"Brain Behav Immun"},{"key":"1558_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB (2015) Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2:258\u2013270","journal-title":"Lancet Psychiatry"},{"key":"1558_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.psyneuen.2008.08.016","volume":"34","author":"M Kluge","year":"2009","unstructured":"Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollm\u00e4cher T (2009) Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 34:118\u2013128","journal-title":"Psychoneuroendocrinology"},{"key":"1558_CR49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0006-3223(90)90480-P","volume":"28","author":"JG Knight","year":"1990","unstructured":"Knight JG, Knight A, Menkes DB, Mullen PE (1990) Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia? Biol Psychiatry 28:467\u2013474","journal-title":"Biol Psychiatry"},{"key":"1558_CR50","doi-asserted-by":"publisher","first-page":"925757","DOI":"10.3389\/fpsyt.2022.925757","volume":"13","author":"A Koricanac","year":"2022","unstructured":"Koricanac A, Tomic Lucic A, Veselinovic M, Bazic Sretenovic D, Bucic G, Azanjac A, Radmanovic O, Matovic M, Stanojevic M, Jurisic Skevin A, Simovic Markovic B, Pantic J, Arsenijevic N, Radosavljevic GD, Nikolic M, Zornic N, Nesic J, Muric N, Radmanovic B (2022) Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia. Front Psychiatry 13:925757","journal-title":"Front Psychiatry"},{"key":"1558_CR51","doi-asserted-by":"crossref","unstructured":"Koskuvi M, P\u00f6rsti E, Hewitt T, R\u00e4s\u00e4nen N, Wu Y-C, Trontti K, McQuade A, Kalyanaraman S, Ojansuu I, Vaurio O (2024) Genetic contribution to microglial activation in schizophrenia. Mol Psychiatry 29:2622\u20132633","DOI":"10.1038\/s41380-024-02529-1"},{"key":"1558_CR52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.psychres.2018.12.138","volume":"272","author":"E Koz\u0142owska","year":"2019","unstructured":"Koz\u0142owska E, Agier J, Wysoki\u0144ski A, \u0141ucka A, Sobierajska K, Brzezi\u0144ska-B\u0142aszczyk E (2019) The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia. Psychiatry Res 272:540\u2013550","journal-title":"Psychiatry Res"},{"key":"1558_CR53","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/schbul\/sbr202","volume":"39","author":"CJ Kuo","year":"2013","unstructured":"Kuo CJ, Yang SY, Liao YT, Chen WJ, Lee WC, Shau WY, Chang YT, Tsai SY, Chen CC (2013) Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull 39:648\u2013657","journal-title":"Schizophr Bull"},{"key":"1558_CR54","doi-asserted-by":"publisher","first-page":"114382","DOI":"10.1016\/j.psychres.2021.114382","volume":"308","author":"C Labont\u00e9","year":"2022","unstructured":"Labont\u00e9 C, Zhand N, Park A, Harvey PD (2022) Complete blood count inflammatory markers in treatment-resistant schizophrenia: evidence of association between treatment responsiveness and levels of inflammation. Psychiatry Res 308:114382","journal-title":"Psychiatry Res"},{"key":"1558_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02870716","volume":"158","author":"H Lehmann-Facius","year":"1937","unstructured":"Lehmann-Facius H (1937) Liquoruntersuehungen Bei Destruktiven Erkrankungen Des Nervensystems, besonders bei Schizophrenie. Z f\u00fcr die Gesamte Neurologie und Psychiatrie 158:109\u2013115","journal-title":"Z f\u00fcr die Gesamte Neurologie und Psychiatrie"},{"key":"1558_CR56","doi-asserted-by":"publisher","first-page":"990307","DOI":"10.3389\/fphar.2022.990307","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Tan Y, Cheng X, Zhang Z, Huang J, Hui S, Zhu L, Liu Y, Zhao D, Liu Z (2022) Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an a\u03b225-35-induced rat model of Alzheimer\u2019s disease. Front Pharmacol 13:990307","journal-title":"Front Pharmacol"},{"key":"1558_CR57","doi-asserted-by":"publisher","first-page":"e13367","DOI":"10.1111\/adb.13367","volume":"29","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yin H, Liu X, Zhang L, Wu D, Shi Y, Chen Y, Zhou X (2024a) Alcohol use disorder and time perception: the mediating role of attention and working memory. Addict Biol 29:e13367","journal-title":"Addict Biol"},{"key":"1558_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10571-024-01481-6","volume":"44","author":"Z-Y Liu","year":"2024","unstructured":"Liu Z-Y, Tang F, Yang J-Z, Chen X, Wang Z-F, Li Z-Q (2024b) The role of Beta2-Microglobulin in Central Nervous System Disease. Cell Mol Neurobiol 44:46","journal-title":"Cell Mol Neurobiol"},{"key":"1558_CR59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphar.2019.00395","volume":"10","author":"H Luo","year":"2019","unstructured":"Luo H, Xiang Y, Qu X, Liu H, Liu C, Li G, Han L, Qin X (2019) Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway. Front Pharmacol 10:395","journal-title":"Front Pharmacol"},{"key":"1558_CR60","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","volume":"89","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatrica Scandinavica 89:346\u2013351","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"1558_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0920-9964(97)00057-1","volume":"26","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY (1997) In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 26:221\u2013225","journal-title":"Schizophr Res"},{"key":"1558_CR62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","volume":"54","author":"M Maes","year":"2002","unstructured":"Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura G-J, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Altamura CA (2002) Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 54:281\u2013291","journal-title":"Schizophr Res"},{"key":"1558_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpsychires.2018.11.008","volume":"109","author":"O Mantere","year":"2019","unstructured":"Mantere O, Trontti K, Garc\u00eda-Gonz\u00e1lez J, Balcells I, Saarnio S, M\u00e4ntyl\u00e4 T, Lindgren M, Kiesepp\u00e4 T, Raij T, Honkanen JK, Vaarala O, Hovatta I, Suvisaari J (2019) Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis. J Psychiatr Res 109:18\u201326","journal-title":"J Psychiatr Res"},{"key":"1558_CR64","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.3390\/jcm10112488","volume":"10","author":"P Marcinowicz","year":"2021","unstructured":"Marcinowicz P, Wi\u0119d\u0142ocha M, Zborowska N, D\u0119bowska W, Podwalski P, Misiak B, Tyburski E, Szulc A (2021) A Meta-analysis of the influence of antipsychotics on cytokines levels in First Episode Psychosis. J Clin Med 10:2488","journal-title":"J Clin Med"},{"key":"1558_CR65","first-page":"1163","volume":"13","author":"M Mauri","year":"2014","unstructured":"Mauri M, Paletta S, Maffini M, Colasanti A, Dragogna F, Di Pace C, Altamura A (2014) Clinical pharmacology of atypical antipsychotics: an update. EXCLI J 13:1163","journal-title":"EXCLI J"},{"key":"1558_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12308-020-00415-7","volume":"13","author":"CMG McNulty","year":"2020","unstructured":"McNulty CMG, Joshi AY (2020) Low class\u2013switched memory B cells predict the need for continued immunoglobulin replacement following B cell reconstitution after Rituximab: a case series and review of the literature. J Hematopathology 13:275\u2013278","journal-title":"J Hematopathology"},{"key":"1558_CR67","first-page":"47","volume":"55","author":"HY Meltzer","year":"1994","unstructured":"Meltzer HY (1994) An overview of the mechanism of action of clozapine. J Clin Psychiatry 55:47\u201352","journal-title":"J Clin Psychiatry"},{"key":"1558_CR68","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","volume":"6","author":"HY Meltzer","year":"2012","unstructured":"Meltzer HY (2012) Clozapine: balancing safety with superior antipsychotic efficacy. Clin Schizophr Relat Psychoses 6:134\u2013144","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"1558_CR69","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663\u2013671","journal-title":"Biol Psychiatry"},{"key":"1558_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","volume":"7","author":"BJ Miller","year":"2014","unstructured":"Miller BJ, Culpepper N, Rapaport MH (2014) C-reactive protein levels in schizophrenia: a review and meta-analysis. Clin Schizophr Relat Psychos 7:223\u2013230","journal-title":"Clin Schizophr Relat Psychos"},{"key":"1558_CR71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.schres.2016.09.016","volume":"178","author":"C Molins","year":"2016","unstructured":"Molins C, Rold\u00e1n A, Corripio I, Isohanni M, Miettunen J, Sepp\u00e4l\u00e4 J, Sepp\u00e4l\u00e4 A, Koponen H, Moilanen J, J\u00e4\u00e4skel\u00e4inen E (2016) Response to antipsychotic drugs in treatment-resistant schizophrenia: conclusions based on systematic review. Schizophr Res 178:64\u201367","journal-title":"Schizophr Res"},{"key":"1558_CR72","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","volume":"41","author":"V Mondelli","year":"2015","unstructured":"Mondelli V, Ciufolini S, Belvederi Murri M, Bonaccorso S, Di Forti M, Giordano A, Marques TR, Zunszain PA, Morgan C, Murray RM, Pariante CM, Dazzan P (2015) Cortisol and inflammatory biomarkers predict poor treatment response in First Episode Psychosis. Schizophr Bull 41:1162\u20131170","journal-title":"Schizophr Bull"},{"key":"1558_CR73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000111535","volume":"56","author":"KS Na","year":"2007","unstructured":"Na KS, Kim YK (2007) Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 56:55\u201363","journal-title":"Neuropsychobiology"},{"key":"1558_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/WNF.0000000000000526","volume":"45","author":"M Nakamura","year":"2022","unstructured":"Nakamura M, Nagamine T (2022) Clozapine-Induced Fever and plasma cytokine changes in a patient with Schizophrenia. Clin Neuropharmacol 45:179\u2013183","journal-title":"Clin Neuropharmacol"},{"key":"1558_CR75","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","volume":"16","author":"C Noto","year":"2015","unstructured":"Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, Brietzke E (2015) High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry 16:422\u2013429","journal-title":"World J Biol Psychiatry"},{"key":"1558_CR76","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","volume":"29","author":"MN Noto","year":"2019","unstructured":"Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA, Cordeiro Q, Belangero SI, Gadelha A, Bressan RA, Noto C (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 29:416\u2013431","journal-title":"Eur Neuropsychopharmacol"},{"key":"1558_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2014.03.020","volume":"156","author":"KE O\u2019Connell","year":"2014","unstructured":"O\u2019Connell KE, Thakore J, Dev KK (2014) Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine. Schizophr Res 156:1\u20138","journal-title":"Schizophr Res"},{"key":"1558_CR78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/acps.12954","volume":"138","author":"C Okhuijsen-Pfeifer","year":"2018","unstructured":"Okhuijsen-Pfeifer C, Huijsman EAH, Hasan A, Sommer IEC, Leucht S, Kahn RS, Luykx JJ (2018) Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis. Acta Psychiatr Scand 138:281\u2013288","journal-title":"Acta Psychiatr Scand"},{"key":"1558_CR79","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"C Pantelis","year":"2014","unstructured":"Pantelis C, Papadimitriou GN, Papiol S, Parkhomenko E, Pato MT, Paunio T, Pejovic-Milovancevic M, Perkins DO, Pietil\u00e4inen O (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421\u2013427","journal-title":"Nature"},{"key":"1558_CR80","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature23013","volume":"547","author":"I Papa","year":"2017","unstructured":"Papa I, Saliba D, Ponzoni M, Bustamante S, Canete PF, Gonzalez-Figueroa P, McNamara HA, Valvo S, Grimbaldeston M, Sweet RA, Vohra H, Cockburn IA, Meyer-Hermann M, Dustin ML, Doglioni C, Vinuesa CG (2017) T(FH)-derived dopamine accelerates productive synapses in germinal centres. Nature 547:318\u2013323","journal-title":"Nature"},{"key":"1558_CR81","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jpsychires.2023.01.042","volume":"160","author":"SR Patlola","year":"2023","unstructured":"Patlola SR, Donohoe G, McKernan DP (2023) Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: a systematic review and meta-analysis. J Psychiatr Res 160:126\u2013136","journal-title":"J Psychiatr Res"},{"key":"1558_CR82","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.tpj.6500179","volume":"3","author":"A Pereira","year":"2003","unstructured":"Pereira A, McLaren A, Bell W, Copolov D, Dean B (2003) Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J 3:227\u2013234","journal-title":"Pharmacogenomics J"},{"key":"1558_CR83","first-page":"1","volume":"214","author":"M Ponsford","year":"2018","unstructured":"Ponsford M, Castle D, Tahir T, Robinson R, Wade W, Steven R, Bramhall K, Moody M, Carne E, Ford C, Farewell D, Williams P, El-Shanawany T, Jolles S (2018) Clozapine is associated with secondary antibody deficiency. Br J Psychiatry 214:1\u20137","journal-title":"Br J Psychiatry"},{"key":"1558_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","volume":"6","author":"SG Potkin","year":"2020","unstructured":"Potkin SG, Kane JM, Correll CU, Lindenmayer J-P, Agid O, Marder SR, Olfson M, Howes OD (2020) The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophrenia 6:1","journal-title":"NPJ Schizophrenia"},{"key":"1558_CR85","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40263-024-01100-4","volume":"38","author":"M Qubad","year":"2024","unstructured":"Qubad M, Dupont G, Hahn M, Martin SS, Puntmann V, Nagel E, Reif A, Bittner RA (2024) When, why and how to re-challenge Clozapine in Schizophrenia following myocarditis. CNS Drugs 38:671\u2013696","journal-title":"CNS Drugs"},{"key":"1558_CR86","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","volume":"140","author":"R R\u00f8ge","year":"2012","unstructured":"R\u00f8ge R, M\u00f8ller BK, Andersen CR, Correll CU, Nielsen J (2012) Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? Schizophr Res 140:204\u2013213","journal-title":"Schizophr Res"},{"key":"1558_CR87","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12035-019-01737-z","volume":"57","author":"C Roomruangwong","year":"2020","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M (2020) The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol 57:778\u2013797","journal-title":"Mol Neurobiol"},{"key":"1558_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","volume":"73","author":"MT Samara","year":"2016","unstructured":"Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, Leucht S (2016) Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant Schizophrenia: A Network Meta-analysis. JAMA Psychiatry 73:199\u2013210","journal-title":"JAMA Psychiatry"},{"key":"1558_CR89","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/nedt.1.2.171.61048","volume":"1","author":"A Schmitt","year":"2005","unstructured":"Schmitt A, Bertsch T, Tost H, Bergmann A, Henning U, Klimke A, Falkai P (2005) Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatr Dis Treat 1:171\u2013177","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1558_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1034\/j.1600-0447.2000.102002153.x","volume":"102","author":"A Schuld","year":"2000","unstructured":"Schuld A, Kraus T, Hinze-Selch D, Haack M, Pollm\u00e4cher T (2000) Granulocyte colony\u2010stimulating factor plasma levels during clozapine\u2010and olanzapine\u2010induced granulocytopenia. Acta Psychiatrica Scandinavica 102:153\u2013155","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"1558_CR91","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.schres.2013.05.018","volume":"148","author":"EG Severance","year":"2013","unstructured":"Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH (2013) Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res 148:130\u2013137","journal-title":"Schizophr Res"},{"key":"1558_CR92","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","volume":"209","author":"D Siskind","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S (2016) Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry 209:385\u2013392","journal-title":"Br J Psychiatry"},{"key":"1558_CR93","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/0004867419898760","volume":"54","author":"D Siskind","year":"2020","unstructured":"Siskind D, Sidhu A, Cross J, Chua YT, Myles N, Cohen D, Kisely S (2020) Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy. Aust N Z J Psychiatry 54:467\u2013481","journal-title":"Aust N Z J Psychiatry"},{"key":"1558_CR94","doi-asserted-by":"publisher","first-page":"120740","DOI":"10.1016\/j.neuroimage.2024.120740","volume":"297","author":"Z Song","year":"2024","unstructured":"Song Z, Jiang Z, Zhang Z, Wang Y, Chen Y, Tang X, Li H (2024) Evolving brain network dynamics in early childhood: insights from modular graph metrics. NeuroImage 297:120740","journal-title":"NeuroImage"},{"key":"1558_CR95","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/schbul\/sbaa031.077","volume":"46","author":"J Steiner","year":"2020","unstructured":"Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S (2020) Innate immune cells and C-reactive protein in acute first-episode psychosis and schizophrenia: relationship to psychopathology and treatment. Schizophr Bull 46:363\u2013373","journal-title":"Schizophr Bull"},{"key":"1558_CR96","doi-asserted-by":"crossref","unstructured":"St\u0119pnicki P, Kondej M, Kaczor AA (2018) Current concepts and treatments of schizophrenia. Molecules 23:2087","DOI":"10.3390\/molecules23082087"},{"key":"1558_CR98","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/YIC.0000000000000162","volume":"32","author":"ZR Stoecker","year":"2017","unstructured":"Stoecker ZR, George WT, O\u2019Brien JB, Jancik J, Colon E, Rasimas JJ (2017) Clozapine usage increases the incidence of pneumonia compared with risperidone and the general population: a retrospective comparison of clozapine, risperidone, and the general population in a single hospital over 25 months. Int Clin Psychopharmacol 32:155\u2013160","journal-title":"Int Clin Psychopharmacol"},{"key":"1558_CR99","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2152\/jmi.71.205","volume":"71","author":"T Takeda","year":"2024","unstructured":"Takeda T, Umehara H, Matsumoto Y, Yoshida T, Nakataki M, Numata S (2024) Schizophrenia and cognitive dysfunction. J Med Invest 71:205\u2013209","journal-title":"J Med Invest"},{"key":"1558_CR100","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fncel.2015.00492","volume":"9","author":"H Wang","year":"2015","unstructured":"Wang H, Liu S, Tian Y, Wu X, He Y, Li C, Namaka M, Kong J, Li H, Xiao L (2015) Quetiapine inhibits microglial activation by neutralizing abnormal STIM1-Mediated Intercellular Calcium Homeostasis and promotes myelin repair in a Cuprizone-Induced mouse model of demyelination. Front Cell Neurosci 9:492","journal-title":"Front Cell Neurosci"},{"key":"1558_CR101","doi-asserted-by":"publisher","first-page":"102280","DOI":"10.1016\/j.pneurobio.2022.102280","volume":"214","author":"H Wang","year":"2022","unstructured":"Wang H, Shang Y, Wang E, Xu X, Zhang Q, Qian C, Yang Z, Wu S, Zhang T (2022) MST1 mediates neuronal loss and cognitive deficits: a novel therapeutic target for Alzheimer\u2019s disease. Prog Neurobiol 214:102280","journal-title":"Prog Neurobiol"},{"key":"1558_CR102","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/00023210-200721010-00003","volume":"21","author":"E Whiskey","year":"2007","unstructured":"Whiskey E, Taylor D (2007) Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs 21:25\u201335","journal-title":"CNS Drugs"},{"key":"1558_CR103","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","volume":"79","author":"JA Williams","year":"2022","unstructured":"Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL, Palmer E, Karwath A, Barsky A, Gkoutos GV, Wood S, Barnes NM, David AS, Donohoe G, Neill JC, Deakin B, Khandaker GM, Upthegrove R (2022) Inflammation and brain structure in Schizophrenia and other Neuropsychiatric disorders: a mendelian randomization study. JAMA Psychiatry 79:498\u2013507","journal-title":"JAMA Psychiatry"},{"key":"1558_CR104","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jpsychires.2012.04.026","volume":"46","author":"MH Xiu","year":"2012","unstructured":"Xiu MH, Chen DC, Wang D, Zhang K, Dong A, Tang W, Zhang F, Liu LJ, Liu JH, Liu HB, Yang FD, Kosten TR, Zhang XY (2012) Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. J Psychiatr Res 46:1093\u20131098","journal-title":"J Psychiatr Res"},{"key":"1558_CR105","doi-asserted-by":"crossref","unstructured":"Ying J, Chew QH, McIntyre RS, Sim K (2023) Treatment-resistant schizophrenia, clozapine resistance, genetic associations, and implications for precision psychiatry: a scoping review. Genes (Basel) 14:689","DOI":"10.3390\/genes14030689"},{"key":"1558_CR106","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00213-022-06067-y","volume":"239","author":"X Yuan","year":"2022","unstructured":"Yuan X, Wang S, Shi Y, Yang Y, Zhang Y, Xia L, Zhang K, Liu H (2022) Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine. Psychopharmacology 239:765\u2013771","journal-title":"Psychopharmacology"},{"key":"1558_CR107","doi-asserted-by":"publisher","first-page":"105010","DOI":"10.1016\/j.neubiorev.2022.105010","volume":"144","author":"U Zahid","year":"2023","unstructured":"Zahid U, Onwordi EC, Hedges EP, Wall MB, Modinos G, Murray RM, Egerton A (2023) Neurofunctional correlates of glutamate and GABA imbalance in psychosis: a systematic review. Neurosci Biobehavioral Reviews 144:105010","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"1558_CR108","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/jamapsychiatry.2024.2185","volume":"81","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Chourpiliadis C, Hammar N, Seitz C, Valdimarsd\u00f3ttir UA, Fang F, Song H, Wei D (2024) Inflammatory biomarkers and risk of Psychiatric disorders. JAMA Psychiatry 81:1118\u20131129","journal-title":"JAMA Psychiatry"},{"key":"1558_CR109","doi-asserted-by":"publisher","first-page":"987293","DOI":"10.3389\/fphar.2022.987293","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang L, Yang Y, Cai C, Wang X, Deng L, He B, Zhou W, Cui Y (2023) DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress. Front Pharmacol 13:987293","journal-title":"Front Pharmacol"},{"key":"1558_CR110","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s00213-021-05824-9","volume":"238","author":"T Zhao","year":"2021","unstructured":"Zhao T, Zhang K, Zhang Y, Yang Y, Ning X, Hu Y, Li X, Zhang Y, Xia L, Ren Z, Liu H (2021) Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders? Psychopharmacology 238:1979\u20131990","journal-title":"Psychopharmacology"},{"key":"1558_CR111","doi-asserted-by":"publisher","first-page":"e93966","DOI":"10.1371\/journal.pone.0093966","volume":"9","author":"F Zhu","year":"2014","unstructured":"Zhu F, Zheng Y, Ding YQ, Liu Y, Zhang X, Wu R, Guo X, Zhao J (2014) Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. PLoS One 9:e93966","journal-title":"PLoS One"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01558-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01558-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01558-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:43:12Z","timestamp":1740822192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01558-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":110,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1558"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01558-1","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics"}},{"value":"It is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}